We found significantly higher serum levels of IL-33 in patients with BC, compared with patients with BBD, and higher expression of IL-33 in carcinomas and adjacent tissues to tumors, compared with normal breast tissue from the same patients. This evidence concerns the gene IL33 and carcinoma.